Mountain Valley MD Holdings Inc. (MVMD.CN)
CAD 0.03
(25.0%)
CAD 0.03
(25.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 258 Thousand CAD | -56.35% |
| 2022 | 591 Thousand CAD | 40.05% |
| 2021 | 422 Thousand CAD | -62.0% |
| 2020 | 1.11 Million CAD | -69.85% |
| 2019 | 3.68 Million CAD | 589.4% |
| 2018 | 534.33 Thousand CAD | 333.24% |
| 2017 | 123.33 Thousand CAD | -71.34% |
| 2016 | 430.34 Thousand CAD | 24.79% |
| 2015 | 344.84 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 283 Thousand CAD | 9.69% |
| 2023 Q3 | 184 Thousand CAD | -41.96% |
| 2023 Q2 | 317 Thousand CAD | -25.41% |
| 2023 FY | 258 Thousand CAD | -56.35% |
| 2023 Q1 | 425 Thousand CAD | -28.09% |
| 2023 Q4 | 258 Thousand CAD | 40.22% |
| 2022 FY | 591 Thousand CAD | 40.05% |
| 2022 Q1 | 457 Thousand CAD | 8.29% |
| 2022 Q4 | 591 Thousand CAD | 24.16% |
| 2022 Q3 | 476 Thousand CAD | -34.34% |
| 2022 Q2 | 725 Thousand CAD | 58.64% |
| 2021 Q3 | 576 Thousand CAD | -15.17% |
| 2021 FY | 422 Thousand CAD | -62.0% |
| 2021 Q4 | 422 Thousand CAD | -26.74% |
| 2021 Q1 | 855 Thousand CAD | -23.02% |
| 2021 Q2 | 679 Thousand CAD | -20.58% |
| 2020 Q4 | 1.11 Million CAD | -62.86% |
| 2020 FY | 1.11 Million CAD | -69.85% |
| 2020 Q3 | 2.99 Million CAD | -9.04% |
| 2020 Q2 | 3.28 Million CAD | -6.39% |
| 2020 Q1 | 3.51 Million CAD | -4.65% |
| 2019 Q3 | 1.01 Million CAD | 67.15% |
| 2019 Q4 | 3.68 Million CAD | 261.82% |
| 2019 Q2 | 609.11 Thousand CAD | 8.34% |
| 2019 Q1 | 562.24 Thousand CAD | 0.0% |
| 2019 FY | 3.68 Million CAD | 589.4% |
| 2018 FY | 534.33 Thousand CAD | 333.24% |
| 2017 FY | 123.33 Thousand CAD | -71.34% |
| 2016 FY | 430.34 Thousand CAD | 24.79% |
| 2015 FY | 344.84 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | 91.214% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 98.198% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | 45.191% |
| The BC Bud Corporation | 626 Thousand CAD | 58.786% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 96.061% |
| CordovaCann Corp. | 11.29 Million CAD | 97.715% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 96.965% |
| Captor Capital Corp. | 28.76 Million CAD | 99.103% |
| City View Green Holdings Inc. | 3.73 Million CAD | 93.089% |
| 1CM Inc. | 9.42 Million CAD | 97.262% |
| Global Hemp Group Inc. | 5.82 Million CAD | 95.571% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 98.782% |
| IM Cannabis Corp. | 35.11 Million CAD | 99.265% |
| Lobe Sciences Ltd. | 2.45 Million CAD | 89.511% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 97.441% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | 94.141% |
| Ovation Science Inc. | 728.99 Thousand CAD | 64.609% |
| Pharmadrug Inc. | 2.92 Million CAD | 91.181% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | 87.649% |
| RAMM Pharma Corp. | 2.83 Million CAD | 90.901% |
| RIV Capital Inc. | 275.63 Million CAD | 99.906% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | 92.421% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 99.929% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 99.314% |
| 1933 Industries Inc. | 23.28 Million CAD | 98.892% |
| Red Light Holland Corp. | 3.82 Million CAD | 93.249% |
| Top Strike Resources Corp. | 20.99 Million CAD | 98.771% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | 67.34% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 98.539% |